SMTL ID : 7jv6.1

SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation)

Coordinates

PDB Format

Method

ELECTRON MICROSCOPY

Oligo State

hetero-3-3-3-mer

Ligands

12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 4 residues within 4Å: Chain A: N.736, L.941, Q.945, Q.1090 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:L.941 NAG-NAG.2: 3 residues within 4Å: Chain A: N.820, S.822, Q.823 No protein-ligand interaction detected (PLIP) NAG-NAG.3: 4 residues within 4Å: Chain A: N.1117, T.1119, H.1120, F.1122 No protein-ligand interaction detected (PLIP) NAG-NAG.4: 1 residues within 4Å: Chain A: N.1153 No protein-ligand interaction detected (PLIP) NAG-NAG.5: 4 residues within 4Å: Chain D: N.736, L.941, Q.945, Q.1090 1 PLIP interactions: 1 interactions with chain D Hydrophobic interactions: D:L.941 NAG-NAG.6: 3 residues within 4Å: Chain D: N.820, S.822, Q.823 No protein-ligand interaction detected (PLIP) NAG-NAG.7: 4 residues within 4Å: Chain D: N.1117, T.1119, H.1120, F.1122 No protein-ligand interaction detected (PLIP) NAG-NAG.8: 1 residues within 4Å: Chain D: N.1153 No protein-ligand interaction detected (PLIP) NAG-NAG.9: 4 residues within 4Å: Chain G: N.736, L.941, Q.945, Q.1090 1 PLIP interactions: 1 interactions with chain G Hydrophobic interactions: G:L.941 NAG-NAG.10: 3 residues within 4Å: Chain G: N.820, S.822, Q.823 No protein-ligand interaction detected (PLIP) NAG-NAG.11: 4 residues within 4Å: Chain G: N.1117, T.1119, H.1120, F.1122 No protein-ligand interaction detected (PLIP) NAG-NAG.12: 1 residues within 4Å: Chain G: N.1153 No protein-ligand interaction detected (PLIP)

36 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.13: 2 residues within 4Å: Chain A: F.78, N.80 Ligand excluded by PLIP NAG.14: 5 residues within 4Å: Chain A: N.141, A.142, T.143, N.144, V.146 Ligand excluded by PLIP NAG.15: 6 residues within 4Å: Chain A: T.127, N.253, T.255 Chain D: R.476, K.481, E.484 Ligand excluded by PLIP NAG.16: 3 residues within 4Å: Chain A: N.299, E.300, N.301 Ligand excluded by PLIP NAG.17: 4 residues within 4Å: Chain A: P.349, N.350, P.598, Q.599 Ligand excluded by PLIP NAG.18: 5 residues within 4Å: Chain A: F.357, G.358, N.362, V.386, L.387 Ligand excluded by PLIP NAG.19: 1 residues within 4Å: Chain A: N.622 Ligand excluded by PLIP NAG.20: 2 residues within 4Å: Chain A: N.635, Q.663 Ligand excluded by PLIP NAG.21: 2 residues within 4Å: Chain A: H.674, N.676 Ligand excluded by PLIP NAG.22: 2 residues within 4Å: Chain A: N.728, G.1150 Ligand excluded by PLIP NAG.23: 3 residues within 4Å: Chain A: A.725, E.1091, N.1093 Ligand excluded by PLIP NAG.24: 2 residues within 4Å: Chain A: E.151, N.184 Ligand excluded by PLIP NAG.25: 2 residues within 4Å: Chain D: F.78, N.80 Ligand excluded by PLIP NAG.26: 5 residues within 4Å: Chain D: N.141, A.142, T.143, N.144, V.146 Ligand excluded by PLIP NAG.27: 6 residues within 4Å: Chain D: T.127, N.253, T.255 Chain G: R.476, K.481, E.484 Ligand excluded by PLIP NAG.28: 3 residues within 4Å: Chain D: N.299, E.300, N.301 Ligand excluded by PLIP NAG.29: 4 residues within 4Å: Chain D: P.349, N.350, P.598, Q.599 Ligand excluded by PLIP NAG.30: 5 residues within 4Å: Chain D: F.357, G.358, N.362, V.386, L.387 Ligand excluded by PLIP NAG.31: 1 residues within 4Å: Chain D: N.622 Ligand excluded by PLIP NAG.32: 2 residues within 4Å: Chain D: N.635, Q.663 Ligand excluded by PLIP NAG.33: 2 residues within 4Å: Chain D: H.674, N.676 Ligand excluded by PLIP NAG.34: 2 residues within 4Å: Chain D: N.728, G.1150 Ligand excluded by PLIP NAG.35: 3 residues within 4Å: Chain D: A.725, E.1091, N.1093 Ligand excluded by PLIP NAG.36: 2 residues within 4Å: Chain D: E.151, N.184 Ligand excluded by PLIP NAG.37: 2 residues within 4Å: Chain G: F.78, N.80 Ligand excluded by PLIP NAG.38: 5 residues within 4Å: Chain G: N.141, A.142, T.143, N.144, V.146 Ligand excluded by PLIP NAG.39: 6 residues within 4Å: Chain A: R.476, K.481, E.484 Chain G: T.127, N.253, T.255 Ligand excluded by PLIP NAG.40: 3 residues within 4Å: Chain G: N.299, E.300, N.301 Ligand excluded by PLIP NAG.41: 4 residues within 4Å: Chain G: P.349, N.350, P.598, Q.599 Ligand excluded by PLIP NAG.42: 5 residues within 4Å: Chain G: F.357, G.358, N.362, V.386, L.387 Ligand excluded by PLIP NAG.43: 1 residues within 4Å: Chain G: N.622 Ligand excluded by PLIP NAG.44: 2 residues within 4Å: Chain G: N.635, Q.663 Ligand excluded by PLIP NAG.45: 2 residues within 4Å: Chain G: H.674, N.676 Ligand excluded by PLIP NAG.46: 2 residues within 4Å: Chain G: N.728, G.1150 Ligand excluded by PLIP NAG.47: 3 residues within 4Å: Chain G: A.725, E.1091, N.1093 Ligand excluded by PLIP NAG.48: 2 residues within 4Å: Chain G: E.151, N.184 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Piccoli, L. et al., Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology. Cell (2020)

Release Date

2020-10-14

Peptides

Spike glycoprotein: ADG
S2H13 Fab heavy chain: BEH
S2H13 Fab light chain: CFI

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

D
B

G
E

B
H

E
C

H
F

C
L

F
D

I
G

Spike glycoprotein

S2H13 Fab heavy chain

S2H13 Fab light chain

Related Entries With Identical Sequence